3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Leukemia, Myeloid, Acute
45
Breast Neoplasms
20
Myelodysplastic Syndromes
19
Prostatic Neoplasms
12
Neoplasms
12
Leukemia, Myelomonocytic, Chronic
12
Carcinoma, Hepatocellular
10
Stomach Neoplasms
9
Recurrence
9
Carcinoma, Non-Small-Cell Lung
8
Neoplasm Metastasis
7
Esophageal Neoplasms
7
Uterine Cervical Neoplasms
6
Sarcoma
6
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Ovarian Neoplasms
6
Multiple Myeloma
6
Lung Neoplasms
6
Myeloproliferative Disorders
5
Melanoma
5
Lymphoma, Non-Hodgkin
5
Lymphoma, B-Cell
5
Esophageal Squamous Cell Carcinoma
5
Colorectal Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
4
Pancreatic Neoplasms
4
Myelodysplastic-Myeloproliferative Diseases
4
Leukemia, Biphenotypic, Acute
4
Leukemia
4
Cholangiocarcinoma
4
Interventions
Tissue Array Analysis
1
Standard of Care
1
Risk Factors
1
Radiotherapy
1
Magnetic Resonance Spectroscopy
1
Injections
1
Ferrosoferric Oxide
1
Clopidogrel
1
Aspirin
1
Anticoagulants
1
Airway Extubation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Ischemic Stroke
×
Injections
×
Clear all
NCT05507645
2024-09-05
PUMICE
Beijing Tiantan Hospital
Phase 3
Completed
1,446 enrolled